Wealth Alliance’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Wealth Alliance's PFE Position: Q1 2026 in Review
Wealth Alliance reduced its Pfizer (PFE) stake by 2.3% in Q1 2026, selling an estimated $58.2K and leaving 91,537 shares worth $2.57M. The position accounts for 0.25% of the portfolio, ranked #84.
Wealth Alliance first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wealth Alliance held 91,537 shares of Pfizer worth $2.57M as of Q1 2026.
- Wealth Alliance sold 2,187 Pfizer shares in Q1 2026, an estimated $58.2K.
- Pfizer made up 0.25% of Wealth Alliance's portfolio in Q1 2026, its #84 holding.
- Wealth Alliance first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.